Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:riluzole
|
| gptkbp:clinical_trial |
60%
|
| gptkbp:dosage_form |
50 mg twice daily
|
| gptkbp:effective_date |
gptkb:1995
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rilutek
|
| gptkbp:ingredients |
gptkb:riluzole
C4 H4 Cl N3 O |
| gptkbp:is_atype_of |
N07 X X02
|
| gptkbp:is_used_for |
gptkb:amyotrophic_lateral_sclerosis
|
| gptkbp:legal_issue |
prescription only
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:side_effect |
dizziness
fatigue headache nausea liver toxicity |